Search
for
Sort by
Research 211–240 of 1000+
- Oral minoxidil bio‐activation by hair follicle outer root sheath cell sulfotransferase enzymes predicts clinical efficacy in female pattern hair loss
- Translation into Portuguese language (Brazil), transcultural adaptation and validation of the quality of life questionnaire in female pattern hair loss (WAA-QoL-BP)
- Genomic and transcriptomic landscape to decipher the genetic basis of hyperpigmentation in Lanping black-boned sheep (Ovis aries)
- Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization
- Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients
- Use of Minoxidil Sulfate versus Minoxidil Base in Androgenetic Alopecia Treatment: Friend or Foe?
- Efficacy of 2.5 mg oral biotin versus 5% topical minoxidil in increasing nail growth rate
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil treatment in Brazilian female pattern hair loss patients
- Aryl hydrocarbon receptor overexpression in miniaturized follicles in female pattern hair loss
- Tratamento de queimaduras de carboxiterapia em modelo experimental
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Ultrastructural evidence for anagen hair follicle infection with SARS‐CoV‐2 in early‐onset COVID‐19 effluvium
- Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5-mg oral minoxidil for androgenetic alopecia
- Prevalence of female pattern hair loss in a multiracial population
- Exuberant tufted folliculitis
- HLA‐B alleles associated with frontal fibrosing alopecia in Brazil may share similar peptide presentation and T‐cell interaction profiles
- Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China
- Brazilian pulmonology guidelines on Delphi panel for post-coronavirus disease 2019
- Can we halt male androgenetic alopecia progression without antiandrogenic drugs?
- Lysocellin, a metabolite of the novel drug ‘alopestatin’, induces G1 arrest and prevents cytotoxicity induced by etoposide
- Association between coronary artery disease and the diagonal earlobe and preauricular creases in men * Associação entre doença arterial coronariana e as pregas lobular diagonal e anterotragal em homens *
- Finasteride-Loaded Phospholipid-Bile Salt Mixed Micelles for Targeted Follicular Delivery in Androgenetic Alopecia.
- Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial
- Oral Minoxidil 2.5mg vs 5mg for Male Androgenetic Alopecia: A Double-Blind Randomized Clinical Trial.
- Response to “Improvement of female pattern hair loss with bicalutamide: a time-dependent process”
- Translation, cultural adaptation and validation of the Brazilian version of the Alopecia Areata Quality of Life Index (AA-QLI-BRA)
- Bicalutamide 25 mg associated with minoxidil 1 mg versus minoxidil 1 mg for female-pattern hair loss: A randomized double-blind clinical trial
- Sublingual Minoxidil 5 mg versus Oral Minoxidil 5 mg for male androgenetic alopecia: A double‐blind randomized clinical trial
- Effect of oral minoxidil 1 mg and 2.5 mg on the growth speed of hair and nails